These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 427973)
41. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions]. Naruszewicz-Lesiuk D; Kańtoch M; Polna I Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837 [No Abstract] [Full Text] [Related]
42. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
43. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111 [TBL] [Abstract][Full Text] [Related]
44. Which measles vaccine at what age? Watson GI R Soc Health J; 1967; 81(5):266-71. PubMed ID: 6064815 [No Abstract] [Full Text] [Related]
45. Risk factors for measles in a vaccinated population. Waters VV; Cook L JAMA; 1991 Mar; 265(12):1527. PubMed ID: 1999897 [No Abstract] [Full Text] [Related]
46. Letter: Defective chemotaxis in measles patients. Anderson R; Sher R; Rabson AR; Koornhof HJ S Afr Med J; 1974 Sep; 48(43):1819-20. PubMed ID: 4608043 [No Abstract] [Full Text] [Related]
48. Electrocardiographic changes in measles. Gupte S Ann Trop Paediatr; 1992; 12(2):229-30. PubMed ID: 1381903 [No Abstract] [Full Text] [Related]
49. [Affection of the central nervous system in rubeola]. Buriakova AV; Tarasova AP Pediatriia; 1969 Mar; 48(3):78-80. PubMed ID: 5802264 [No Abstract] [Full Text] [Related]
51. 'Then Came the Measles': Tom Sawyer's Rubeola Infection. Hoenig LJ Am J Med; 2019 Oct; 132(10):1247-1248. PubMed ID: 31150641 [No Abstract] [Full Text] [Related]
52. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca]. Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414 [TBL] [Abstract][Full Text] [Related]
53. [The course of measles in vaccinated and nonvaccinated children]. Plesník V; Pĕtvaldská L; Vrzáková A Cesk Pediatr; 1979 Mar; 34(3):155-8. PubMed ID: 427973 [No Abstract] [Full Text] [Related]
54. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy. Yuan L CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali. Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894 [TBL] [Abstract][Full Text] [Related]
56. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Marks JS; Halpin TJ; Orenstein WA Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423 [TBL] [Abstract][Full Text] [Related]